BRPI0913337A2 - liberação pulsátil de valsartan - Google Patents

liberação pulsátil de valsartan

Info

Publication number: BRPI0913337A2
Authority: BR; Brazil
Prior art keywords: valsartan; pulsatile release; pulsatile; release
Prior art date: 2008-06-03

Application number

BRPI0913337A

Other languages

English (en)

Inventor

Taillardat Agnes

Singh Matharu Amol

Frank Wagner Robert

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-03

Filing date

2009-06-01

Publication date

2017-05-23

2009-06-01 Application filed by Novartis Ag filed Critical Novartis Ag

2017-05-23 Publication of BRPI0913337A2 publication Critical patent/BRPI0913337A2/pt

Links

239000004072 C09CA03 - Valsartan Substances 0.000 title 1
230000000541 pulsatile effect Effects 0.000 title 1
SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 title 1
229960004699 valsartan Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0913337A 2008-06-03 2009-06-01 liberação pulsátil de valsartan BRPI0913337A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5823308P	2008-06-03	2008-06-03
PCT/US2009/045786 WO2009148990A1 (en)	2008-06-03	2009-06-01	Pulsatile release of valsartan

Publications (1)

Publication Number	Publication Date
BRPI0913337A2 true BRPI0913337A2 (pt)	2017-05-23

Family

ID=40974663

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0913337A BRPI0913337A2 (pt)	2008-06-03	2009-06-01	liberação pulsátil de valsartan

Country Status (10)

Country	Link
US (1)	US20110189286A1 (pt)
EP (1)	EP2285358A1 (pt)
JP (1)	JP2011522050A (pt)
KR (1)	KR20110015650A (pt)
CN (1)	CN102046154A (pt)
AU (1)	AU2009256423A1 (pt)
BR (1)	BRPI0913337A2 (pt)
CA (1)	CA2726793A1 (pt)
MX (1)	MX2010013238A (pt)
WO (1)	WO2009148990A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102028659A (zh) *	2010-12-16	2011-04-27	苏州大学	一种缬沙坦生物粘附性包衣微丸制剂及其制备方法
CN102133197B (zh) *	2011-03-18	2012-06-27	海南美兰史克制药有限公司	一种缬沙坦脂微球固体制剂
CN102626395B (zh) *	2012-04-19	2014-02-26	海南美兰史克制药有限公司	一种阿利克仑缬沙坦药物组合物脂质体固体制剂
KR101269829B1 (ko) *	2012-04-27	2013-05-30	씨제이제일제당 (주)	위체류 약물전달 시스템을 이용한 서방성 제제
CN102641253B (zh) *	2012-05-07	2013-10-09	山东省医药工业研究所	缬沙坦缓释片及其制备方法
WO2014059430A1 (en) *	2012-10-14	2014-04-17	Board Of Regents, The University Of Texas System	Delivery of small interfering rna and micro rna through membrane-disruptive, responsive nanoscalle hydrogels
ES2821528T3 (es)	2012-11-14	2021-04-26	Grace W R & Co	Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
WO2015028972A1 (en)	2013-09-02	2015-03-05	Ranbaxy Laboratories Limited	Pulsatile-release dosage form
WO2018002673A1 (en) *	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists
KR101920628B1 (ko) *	2017-04-12	2018-11-22	대원제약주식회사	안지오텐신 수용체 길항제를 포함하는 약제학적 조성물
CN113133978B (zh) *	2020-01-20	2023-10-17	鲁南制药集团股份有限公司	一种阿齐沙坦片及其制备方法
KR20220091767A (ko) *	2020-12-24	2022-07-01	주식회사 보령	사쿠비트릴 발사르탄 하이브리드 화합물 또는 그 약제학적으로 허용되는 염을 유효성분으로 포함하는 약제학적 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008536929A (ja) *	2005-04-18	2008-09-11	ルビコン・リサーチ・ピーヴィーティー・エルティーディー	生体強化組成物
PE20080907A1 (es) *	2006-08-31	2008-08-22	Novartis Ag	Sistema de suministro de farmaco oral gastro-retentivo de liberacion extendida para valsartan
WO2008064338A2 (en) *	2006-11-22	2008-05-29	Rubicon Research Pvt. Ltd.	Valsartan formulation for pulsatile delivery
WO2008084504A2 (en) *	2007-01-12	2008-07-17	Rubicon Research Private Limited	Pharmaceutical compositions of angiotensin ii receptor blockers
EP2192892A2 (en) *	2007-07-27	2010-06-09	Depomed, Inc.	Pulsatile gastric retentive dosage forms

2009
- 2009-06-01 AU AU2009256423A patent/AU2009256423A1/en not_active Abandoned
- 2009-06-01 MX MX2010013238A patent/MX2010013238A/es not_active Application Discontinuation
- 2009-06-01 US US12/995,577 patent/US20110189286A1/en not_active Abandoned
- 2009-06-01 EP EP09759151A patent/EP2285358A1/en not_active Withdrawn
- 2009-06-01 CA CA2726793A patent/CA2726793A1/en not_active Abandoned
- 2009-06-01 WO PCT/US2009/045786 patent/WO2009148990A1/en not_active Ceased
- 2009-06-01 BR BRPI0913337A patent/BRPI0913337A2/pt not_active IP Right Cessation
- 2009-06-01 KR KR1020107029694A patent/KR20110015650A/ko not_active Withdrawn
- 2009-06-01 CN CN2009801204840A patent/CN102046154A/zh active Pending
- 2009-06-01 JP JP2011512556A patent/JP2011522050A/ja active Pending

Also Published As

Publication number	Publication date
EP2285358A1 (en)	2011-02-23
CN102046154A (zh)	2011-05-04
CA2726793A1 (en)	2009-12-10
AU2009256423A1 (en)	2009-12-10
WO2009148990A1 (en)	2009-12-10
US20110189286A1 (en)	2011-08-04
KR20110015650A (ko)	2011-02-16
JP2011522050A (ja)	2011-07-28
MX2010013238A (es)	2010-12-21

Legal Events

Date	Code	Title
2017-06-06	B08F	Application fees: application dismissed [chapter 8.6 patent gazette]
2017-09-19	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
2021-07-13	B350	Update of information on the portal [chapter 15.35 patent gazette]

Publication	Publication Date	Title
BRPI0913337A2 (pt)	2017-05-23	liberação pulsátil de valsartan
BRPI1013622A2 (pt)	2016-10-25	cápsula liberadora
GB2473392B (en)	2013-03-06	Methods of diagnosis
BRPI0914630A2 (pt)	2019-09-24	liberação dérmica
EP2296593A4 (en)	2015-01-14	MEDICAL HEAD COVER
BRPI0911101A2 (pt)	2015-10-06	cápsula endoscópica
DE602009000580D1 (de)	2011-03-03	Endoskopsystem
EP2124523A4 (en)	2010-08-04	BREEDING LINE P2428-5006090
EP2418213A4 (en)	2012-12-19	NEURO MEDIN-U DERIVATIVE
BRPI0918249A2 (pt)	2015-12-15	prótese
DE112010001657A5 (de)	2012-12-20	Kupplungsparameter
BR112012002271A2 (pt)	2016-06-14	cápsulas de liberação sustentada
ZA201102604B (en)	2012-09-26	Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
EP2349335A4 (en)	2012-02-08	LEVETIRACETAM IMMUNOASSAYS
PL2133419T3 (pl)	2019-02-28	Zastosowania beta-dipeptydów cyjanoficyny
PT2492266E (pt)	2015-11-18	Derivado de 5-hidroxipirimidino-4-carboxamida
DE112009002641A5 (de)	2013-10-02	Klemmkörperfreilauf
CU23884B1 (es)	2013-04-19	Derivados de dibenzotiazepina
FI20096402A0 (fi)	2009-12-28	Veriryhmästatuksen käyttö II
BRPI0920833A2 (pt)	2015-12-22	preparação de benzonorborbenos
DE112010001788A5 (de)	2012-07-05	Kupplung
DK2173197T3 (da)	2019-09-23	Fremgangsmåde
FR2929506B1 (fr)	2015-01-09	Orthese de contention
DE112009002440A5 (de)	2011-07-14	Kupplung
BRPI0913967A2 (pt)	2015-11-17	freio